Table 2.

Comparison of Population Characteristics, With and Without Pulmonary Embolism.

Characteristic No PE (n=122) PE (n=35) P-value
Sex, n (%)
 Male 52 (43%) 12 (34%)
 Female 90 (57%) 23 (66%)
Medications, n (%)
 Aspirin 31 (25%) 15 (42%) 0.06
 Clopidogrel 13 (10%) 2 (6%) 0.52
 Warfarin 1 (<1%) 1 (3%) 0.39
 NOAC/LMWH 9 (7%) 1 (3%) 0.45
Age (years), mean (SD) 77.3 (8.8) 79.9 (8.6) 0.10
D-dimer (μg/mL), mean (SD) 6.73 (11.72) 12.63 (13.9) 0.02
Fibrinogen (mg/dL), mean (SD) 462 (182) 429 (134) 0.25
Platelet (1000/μL), mean (SD) 261 (156) 204 (84) <0.01
Neutrophil abs (1000/μL), mean (SD) 7.30 (4.50) 7.60 (2.51) 0.60
Lymphocyte abs (1000/μL), mean (SD) 1.28 (0.76) 1.55 (1.17) 0.19
CRP (mg/dL), mean (SD) 8.10 (8.8*) 7.83 (5.96) 0.83
Albumin (g/dL), mean (SD) 3.40 (0.40) 3.30 (0.50) 0.48
Calcium (mg/dL), mean (SD) 8.7 (0.70) 8.84 (0.84) 0.34
INR, mean (SD) 1.18 (0.92) 1.07 (0.12) 0.23
PT (s), mean (SD) 11.46 (1.81) 11.23 (1.08) 0.37
aPTT (s), mean (SD) 25.9 (7.50) 23.7 (3.55) 0.02
MPV (fL), mean (SD) 8.75 (1.20) 9.20 (1.20) 0.07
Padua, mean (SD) 3.76 (2.48) 5.60 (2.10) <0.01
* The higher standard deviation of the CRP than the mean is due to very high CRP value in some patients.

abs, absolute; aPTT, activated partial thromboplastin time; CRP, C-reactive protein; INR, international normalized ratio; LMWH, low-molecular-weight heparin; MPV, mean platelet volume; NOAC, non-vitamin K antagonist oral anticoagulant; PE, pulmonary embolism; PT, prothrombin time; SD, standard deviation.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2025; 16(3): e0013. ISSN: 2076-9172
Published online 2025 July 31. doi: 10.5041/RMMJ.10548